退伍军人在联邦医疗保险优势计划与传统联邦医疗保险中的临终关怀:风险调整分析
该研究基于2008至2013年间同时参加退伍军人健康管理局与联邦医疗保险优势计划或传统联邦医疗保险的退伍军人死亡数据,比较两类保险下临终关怀的使用与时长。风险调整分析显示,优势计划受益者更可能接受临终关怀,但临终关怀时长更短,与非风险调整分析方向相反。
要点
- 风险调整后,联邦医疗保险优势计划受益者比传统联邦医疗保险受益者更可能接受临终关怀。
- 风险调整后,优势计划受益者的临终关怀时长更短,与非风险调整分析方向相反。
- 联邦医疗保险优势计划与传统联邦医疗保险的比较需恰当风险调整以获正确效应方向。
核心结论
- 联邦医疗保险优势计划受益者接受的临终关怀质量较传统联邦医疗保险受益者差,依据为临终关怀暴露情况。
- 联邦医疗保险优势计划与传统联邦医疗保险之间的任何比较均需恰当风险调整以获得正确的效应方向。
研究设计与样本
- 回顾性行政数据分析,研究对象为2008至2013年间死亡、同时参加退伍军人健康管理局与联邦医疗保险优势计划或传统联邦医疗保险的退伍军人(N=1,515,441)。
主要发现
- 风险调整分析显示,联邦医疗保险优势计划受益者比传统联邦医疗保险受益者更可能接受临终关怀,结果与已发表的非风险调整分析一致。
- 联邦医疗保险优势计划受益者的临终关怀时长更短,与非风险调整分析的方向相反。
- 结果在多项敏感性分析中稳健,这些分析将队列限制为联邦医疗保险优势计划与传统联邦医疗保险中合并症被捕获机会均等的个体。
- 去除风险调整后,结果与现有已发表文献一致。
临床怎么用
- 在比较联邦医疗保险优势计划与传统联邦医疗保险的临终关怀质量时,应采用恰当风险调整以获正确效应方向。
- 联邦医疗保险优势计划受益者的临终关怀使用与时长评估需考虑风险调整后的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the quality of end-of-life care in Medicare Advantage (MA) and traditional Medicare (TM), specifically, receipt and length of hospice care. DESIGN: Retrospective analysis of administrative data. SETTING: Hospice care. PARTICIPANTS: Veterans dually enrolled in the Veterans Health Administration (VHA) and MA or TM who died between 2008 and 2013 (N = 1,515,441). MEASUREMENTS: Outcomes studied included use and duration of hospice care. Use of a VHA-enrolled population allowed for risk adjustment that is otherwise challenging when studying MA. RESULTS: Adjusted analyses revealed that MA beneficiaries were more likely to receive hospice than TM beneficiaries; results corroborate published non-risk-adjusted analyses. MA beneficiaries had shorter hospice duration; this is an opposite direction of effect than non-risk-adjusted analyses. Results were robust to multiple sensitivity analyses limiting the cohort to individuals in MA and TM who had equal opportunity for their comorbidities to be captured. Removing risk adjustment resulted in results that mirrored those in the existing published literature. CONCLUSION: Our work provides two important insights regarding MA that are important to consider as enrollment in this insurance mechanism grows. First, MA beneficiaries received poorer-quality end-of-life care than TM beneficiaries, as ascertained by exposure to hospice. Second, any comparisons made between MA and TM require proper risk adjustment to obtain correct directions of effect. We encourage the Centers for Medicare & Medicaid Services to make comorbidity data specific to MA enrollees available to researchers for these purposes.
引用
- Gidwani-Marszowski R, Kinosian B, Scott W, et al. Hospice Care of Veterans in Medicare Advantage and Traditional Medicare: A Risk-Adjusted Analysis. J Am Geriatr Soc. 2018. PMID: 30091240. doi:10.1111/jgs.15434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。